Published in Am J Infect Dis on January 01, 2006
Expression of HIV-Tat protein is associated with learning and memory deficits in the mouse. Behav Brain Res (2011) 1.13
HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities. Biomed Res Int (2015) 0.89
Testing a Computerized Cognitive Training Protocol in Adults Aging With HIV-Associated Neurocognitive Disorders: Randomized Controlled Trial Rationale and Protocol. JMIR Res Protoc (2017) 0.75
Psychiatric morbidity in asymptomatic human immunodeficiency virus patients. Ind Psychiatry J (2013) 0.75
The impact of cognitive training in substance use disorder: the effect of working memory training on impulse control in methamphetamine users. Psychopharmacology (Berl) (2017) 0.75
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30
Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med (1985) 6.54
The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38
Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS (2004) 5.04
Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology (2002) 4.67
HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology (2001) 3.55
Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence. J Neurosci (2001) 3.46
Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc (2004) 3.21
Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol (2003) 2.93
Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A (2005) 2.79
Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology (2004) 2.54
Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med (1987) 2.46
Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology (2005) 2.45
Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study. Neurology (2000) 2.26
Neuropsychological performance in HIV-1-infected homosexual men: The Multicenter AIDS Cohort Study (MACS) Neurology (1990) 2.17
Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy. J Infect Dis (2003) 2.16
Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: a review. J Neuropsychiatry Clin Neurosci (2003) 2.14
Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection. J Int Neuropsychol Soc (2000) 1.90
Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men. Neurology (1991) 1.88
Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr (2002) 1.83
Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology (1993) 1.68
Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain (2004) 1.61
The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease. AIDS (2005) 1.55
Psychiatric and neurocognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site Study. AIDS (2004) 1.54
Personality disorder in patients infected with HIV: a controlled study with implications for clinical care. Am J Psychiatry (1993) 1.53
DSM-III personality disorder diagnoses in a nonpatient sample. Demographic correlates and comorbidity. Arch Gen Psychiatry (1989) 1.50
Predictors of neuropsychological performance in HIV positive women. J Clin Exp Neuropsychol (2001) 1.39
Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol (2001) 1.35
Apathy, depression, and cognitive performance in HIV-1 infection. J Neuropsychiatry Clin Neurosci (1998) 1.32
Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. J Clin Epidemiol (2001) 1.31
Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis (2008) 1.30
HIV infection and dementia in older adults. Clin Infect Dis (2006) 1.28
An overview of the global HIV/AIDS epidemic, with a focus on the United States. AIDS (2000) 1.22
Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the multicenter AIDS Cohort Study (MACS). J Acquir Immune Defic Syndr (1993) 1.20
Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection. AIDS Behav (2006) 1.19
The effect of recent stimulant use on sustained attention in HIV-infected adults. J Clin Exp Neuropsychol (2006) 1.17
Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessment of current and lifetime psychopathology. Arch Gen Psychiatry (1991) 1.17
The effect of previous alcohol abuse on cognitive function in HIV infection. Am J Psychiatry (2004) 1.12
Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study. Compr Psychiatry (1997) 1.10
Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med (1996) 1.09
Prevalence of DSM-III personality disorders in the community. Soc Psychiatry Psychiatr Epidemiol (1989) 1.08
Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clin Infect Dis (2005) 1.07
Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain. Exp Neurol (2003) 1.06
Neuropsychological functioning in HIV-positive African-American women with a history of drug use. J Natl Med Assoc (1998) 1.04
DSM-III personality disorders in the community. Am J Psychiatry (1994) 1.03
Alcohol-related risk factors associated with HIV infection among patients entering alcoholism treatment: implications for prevention. J Stud Alcohol (1995) 1.03
Auditory working memory in HIV-1 infection. J Int Neuropsychol Soc (2001) 1.03
Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology (1999) 1.02
Diagnosing personality disorders in the community. A comparison of self-report and interview measures. Arch Gen Psychiatry (1990) 1.01
Cerebral metabolic change in patients with AIDS: report of a six-month follow-up using positron-emission tomography. J Neuropsychiatry Clin Neurosci (1995) 1.01
Neuropsychological performance in HIV-1 immunocompromised patients: a preliminary report. J Clin Exp Neuropsychol (1989) 1.01
HIV-1 infection and intravenous drug use: longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology (1992) 0.98
HIV infection and cognition in intravenous drug users: long-term follow-up. Neurology (1997) 0.96
Relationship between alcohol use/abuse, HIV infection and neuropsychological performance in African American men. J Clin Exp Neuropsychol (2006) 0.95
Dual task performance in HIV-1 infection. J Clin Exp Neuropsychol (2000) 0.94
Delayed recognition memory span in HIV-1 infection. J Int Neuropsychol Soc (1995) 0.93
Computerized and traditional stroop task dysfunction in HIV-1 infection. Neuropsychology (1999) 0.93
AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy. AIDS (2001) 0.92
Human immunodeficiency virus-type 1 (HIV-1) and the brain. J Consult Clin Psychol (1990) 0.91
HIV-1, cocaine, and neuropsychological performance in African American men. J Int Neuropsychol Soc (2000) 0.91
Axis I psychiatric symptoms associated with HIV infection and personality disorder. Am J Psychiatry (1995) 0.91
Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users. J Magn Reson Imaging (1999) 0.90
Drug abuse and psychiatric findings in HIV-seropositive pregnant patients. Gen Hosp Psychiatry (1991) 0.88
Effects of past noninjection drug abuse upon executive function and working memory in HIV infection. J Clin Exp Neuropsychol (2003) 0.88
Prevalence of psychiatric disorders in a mandatory screening program for infection with human immunodeficiency virus: a pilot study. Mil Med (1990) 0.86
Do drugs of abuse impact on HIV disease? J Neuroimmunol (2004) 0.85
Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. Am J Epidemiol (1992) 0.84
Antisocial personality in treatment-seeking cocaine abusers: Psychosocial functioning and HIV risk. J Subst Abuse Treat (2003) 0.82
Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci (1993) 0.81
Axis II diagnoses among volunteers for HIV testing and counseling. Am J Psychiatry (1995) 0.81
Relationship of cognitive ability to the developmental course of antisocial behavior in substance-dependent patients. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.79
Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Relationship to head injury. Arch Neurol (1992) 0.78
Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol (2004) 5.18
Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status. Health Psychol (2007) 2.62
Aging, neurocognition, and medication adherence in HIV infection. Am J Geriatr Psychiatry (2009) 1.64
Functional consequences of HIV-associated neuropsychological impairment. Neuropsychol Rev (2009) 1.54
Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology (2010) 1.50
Medication and finance management among HIV-infected adults: the impact of age and cognition. J Clin Exp Neuropsychol (2010) 1.46
Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring. Health Psychol (2006) 1.41
Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS Behav (2011) 1.35
Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS Behav (2005) 1.31
Depression, cognition, and self-appraisal of functional abilities in HIV: an examination of subjective appraisal versus objective performance. Clin Neuropsychol (2011) 1.21
The effect of recent stimulant use on sustained attention in HIV-infected adults. J Clin Exp Neuropsychol (2006) 1.17
Differential predictors of medication adherence in HIV: findings from a sample of African American and Caucasian HIV-positive drug-using adults. AIDS Patient Care STDS (2012) 1.16
Risky decision making assessed with the gambling task in adults with HIV. Neuropsychology (2006) 1.09
Reaction time performance in adults with HIV/AIDS. J Clin Exp Neuropsychol (2002) 1.09
Components of depression in HIV-1 infection: their differential relationship to neurocognitive performance. J Clin Exp Neuropsychol (2006) 1.08
Neuropsychological aspects of coinfection with HIV and hepatitis C virus. Clin Infect Dis (2005) 1.07
Neurocognitive functioning in HIV-1 infection: effects of cerebrovascular risk factors and age. Clin Neuropsychol (2010) 1.02
Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy. Metab Brain Dis (2011) 1.00
Functional disability in medication management and driving among individuals with HIV: a 1-year follow-up study. J Clin Exp Neuropsychol (2012) 0.95
Reaction time variability in HIV-positive individuals. Arch Clin Neuropsychol (2010) 0.94
Elements of attention in HIV-infected adults: evaluation of an existing model. J Clin Exp Neuropsychol (2007) 0.93
Relationship between psychiatric status and frontal-subcortical systems in HIV-infected individuals. J Int Neuropsychol Soc (2007) 0.93
CCL3 genotype and current depression increase risk of HIV-associated dementia. Neurobehav HIV Med (2009) 0.93
Basal ganglia structures differentially contribute to verbal fluency: evidence from Human Immunodeficiency Virus (HIV)-infected adults. Neuropsychologia (2011) 0.92
Emerging issues in the neuropsychology of HIV infection. Curr HIV/AIDS Rep (2008) 0.88
The impact of neurobehavioral features on medication adherence in HIV: evidence from longitudinal models. AIDS Care (2013) 0.88
The Item-Specific Deficit Approach to evaluating verbal memory dysfunction: rationale, psychometrics, and application. J Clin Exp Neuropsychol (2009) 0.87
Perceptual span deficits in adults with HIV. J Int Neuropsychol Soc (2004) 0.87
An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults. J Clin Exp Neuropsychol (2008) 0.87
Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease. BMC Med Genomics (2013) 0.86
2D MR Spectroscopy Combined with Prior-Knowledge Fitting Is Sensitive to HCV-Associated Cerebral Metabolic Abnormalities. Int J Hepatol (2012) 0.86
Cognitive reserve as a protective factor in older HIV-positive patients at risk for cognitive decline. Appl Neuropsychol Adult (2012) 0.85
Reaction time slowing in adults with HIV: results of a meta-analysis using brinley plots. Brain Cogn (2002) 0.83
The role of HIV infection, cognition, and depression in risky decision-making. J Neuropsychiatry Clin Neurosci (2012) 0.83
Antiretroviral adherence and the nature of HIV-associated verbal memory impairment. J Neuropsychiatry Clin Neurosci (2011) 0.82
The generalizability of neurocognitive test/retest data derived from a nonclinical sample for detecting change among two HIV+ cohorts. J Clin Exp Neuropsychol (2007) 0.82
Subcortical hyperintensities in Alzheimer's disease: associated clinical and metabolic findings. J Neuropsychiatry Clin Neurosci (2002) 0.82
Effects of stereotype threat, perceived discrimination, and examiner race on neuropsychological performance: simple as black and white? J Int Neuropsychol Soc (2013) 0.81
Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine. Neurology (2005) 0.81
Sensation seeking and visual selective attention in adults with HIV/AIDS. AIDS Behav (2007) 0.81
The aggregate effects of multiple comorbid risk factors on cognition among HIV-infected individuals. J Clin Exp Neuropsychol (2013) 0.78
The role of chemokine C-C motif ligand 2 genotype and cerebrospinal fluid chemokine C-C motif ligand 2 in neurocognition among HIV-infected patients. AIDS (2015) 0.78
Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo. J Magn Reson Imaging (2010) 0.78
A deconstruction of gambling task performance among HIV+ individuals: the differential contributions of problem solving and risk taking. J Clin Exp Neuropsychol (2013) 0.76
Neuropsychological exploration of alleged mold neurotoxicity. Arch Clin Neuropsychol (2007) 0.75
Stability of human immunodeficiency virus type 1 RNA in cerebrospinal fluid determined with the AMPLICOR HIV-1 MONITOR test, version 1.5 (ultrasensitive). J Clin Microbiol (2002) 0.75
Longitudinal Intra-Individual Variability in Neuropsychological Performance Relates to White Matter Changes in HIV. Neuropsychology (2017) 0.75